Search
Lyell Immunopharma's CEO on the future of TIL and CAR-T therapies for solid tumor targets
On the heels of a historic recent approval for the class, Lynn Seely describes the science behind TIL therapies.
Feb 26, 2024
top of page
Search
Follow BiotechTV
Also look for unique social pages for BiotechTV U.
.png){kind=logo}
Sponsor Spotlight
Allucent Clinical Research Organization™ is on a mission to help bring new therapies to light by solving the distinct challenges of small and mid-sized biotech companies. We’re a global provider of comprehensive drug development solutions, including consulting, clinical operations, biometrics, and clinical pharmacology across a variety of therapeutic areas.
bottom of page